Navigation Links
Malawi Targets 150,000 People With AIDS Drugs

Malawi has set itself a target of supplying 150,000 HIV sufferers with free anti-retroviral drugs by the end of year, the head of the national AIDS commission (NAC) said on Monday .

"We are close to 110,000 people on ARVs and we hope to hit 150,000 by the end of December when we launch a massive scale-up of the drugs" from September, NAC chief Biziwick Mwale told AFP.

The increase would be underwritten by a new batch of funding from the global fund against AIDS, tuberculosis and malaria.

Malawi first launched a free ARV programme in 2004 but only 5,000 people were initial beneficiaries.

Mwale said the massive increase in the scale of the programme meant that three-quarters of HIV patients who are need of ARVs would be receiving the drugs by the end of the year.

"It's quite tremendous and we are on course and superceeding our overall (target) rates when we consider that we had less than 5,000 people on ARVs in 2004" he said.

Mwale said the number of Malawians going for voluntary HIV tests had now risen to 500,000 every year, from less than 50,000 three years ago.

The biggest impediment to the roll-out programme was the shortage of health workers, the NAC chief added.

Malawi, with a population of 12 million, has only 150 doctors on the state payroll, according to a recent survey by the health ministry.

Still a taboo subject in the conservative landlocked country, wedged between Tanzania, Mozambique and Zambia, some 930,000 Malawians are living with HIV or AIDS where the prevalence rate is 14 percent, according to UN AIDS.

There are about 78,000 AIDS-related deaths every year.


'"/>




Page: 1

Related medicine news :

1. Avian flu scare in Malawi too!!
2. Eating Contaminated Food Leads To Cholera Outbreak In Malawi
3. Malawi Has More Work Against Aids - UN Reports
4. HIV /AIDS testing center at Malawis parliament.
5. First Paediatric AIDS clinic in Malawi
6. Clinton to Launch 70m Dollar Hospital Project in Malawi
7. Sexually Active Malawians Urged to Take HIV Tests
8. Research Targets treatment for dementia and brain injuries
9. Cancer Treatments Fall Short Of Targets
10. India Targets Eliminating Leprosy
11. Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Malawi Targets People With AIDS Drugs

(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...uthor James A. Feinstein, MD, has just released hi...s from Patients on Becoming a Doctor, that traces ...hool--the grueling clinical year. , ...009 -- Most people will, at some point or another,... gown or staring at someone else dressed in a tiny...
(Date:12/2/2009)...e-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: G...y Health Care Conference today at 2:30 p.m. Easter...t live and may be accessed through a link on the i...n-probe.com . The webcast will be available for 30... ,, Gen-Probe Incorporated is a global leader ...
(Date:12/2/2009)...wire/ -- LeapFrog Investments has announced a ZAR ...fe, the innovative South African insurer serving p... brings together LeapFrog, the leading microinsura...most innovative insurance businesses. The announce...fe has developed a distinctive and profitable busi...
(Date:12/2/2009)...cal trial presented today at the annual meeting of...provide the first strong evidence of the benefit o... breasts who are at elevated risk for breast cance...ghly sensitive in depicting early breast cancer. ,... in addition to mammography significantly improves...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2
...ovember issue of Developmental Psychology has expl...picture-book reading with their children, // which...them to the world outside. This is thought to be h... and spend approximately 40 minutes a day reading ...
...la will soon head for the Maldives to care for pat...s from Kerala are to leave for the Maldives courte... Promotion Consultants (ODEPC). 'The first b.... 'The Maldives has also asked us to recruit...
...d? Yes, within the brain, say researchers. Brain ...essing mechanism has never been easy. //Meditators...ntly chattering. Researchers have come up with a f...n you least expect it. We often experience that th...
...ual health campaign is targeting young adults to c...r focus is mainly on 18 to 24-year-olds. //Current...ed to carry condoms on a night out. The ?4m ca...ealth groups but pointed out that a further ?46m h...
...captured the imagination of the world as a 'repeto...joled into restoring or rejuvenating debilitating ...ientists have helped to reiterate this belief, by ... could be lauded as a 'mile stone' in stem cell re...
...opular world over for its quality poultry products...ed to a record 3.26 Billion Rupees. //However the ...rldwide epidemic brought the poultry revenues cras...Influenza' has been known to affect humans though ...
Other Medicine News:Health News:Picture Book Reading Helps Toddlers Grasp Complex Actions 2Health News:Noise In Neurons Is good 2Health News:Risk-Taking Young Urged To Carry Condoms 2Health News:Research 'Extraordinaire' To Restore Vision 2Health News:India Free From Bird Flu 2
(Date:12/1/2009)...., Dec. 1 CeloNova BioSciences, In... medical devices and of specialty implants, today ..., founder and medical director of Baptist Cardiac ...iscuss the CATANIA(TM) Stent System with NanoThin ...lar Interventions Conference to be held at the Hot...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
(Date:12/1/2009)...., Dec. 1 SCOLR Pharma, ... 20, 2009 it licensed to Chrono Nutraceuticals LLC...l four extended release dietary supplements using ...rm. In addition, SCOLR granted Chrono rights to m...ited States on a nonexclusive basis. Chrono paid ...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 1Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 2Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 3The tourist trap 9540 1
...ial New Front-Line Treatment ...Genzyme Corp.,(Nasdaq: GENZ ) reported preliminar...2 study examining the safety and effectiveness of ...ously untreated, older adult,patients with acute m...fit,from conventional "7+3" anthracycline plus cyt...
...CALS, INC. (Nasdaq: VION ) today announced that i... lead anticancer agent Cloretazine(R),(VNP40101M) ...yelogenous,leukemia (AML) had been presented at th...linical Oncology (ASCO(R)) in Chicago, Illinois., ...atients. The median,age of these patients was 73 y...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4
Fast-Cath™ Guiding Introducers
Lumenis 1000 Integrated Slit Lamp
Novus 30001
Selecta Trio Photocoagulator and SLT Combination Laser
Medicine Products: